Resurrected pandemic influenza viruses

Annual Review of Microbiology

Volumn 63, Issue , 2009, Pages 79-98

  Tumpey, Terrence M ^a   Belser, Jessica A ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Adaptation; Pathogenesis; Transmission; Virus genes

Indexed keywords

HEMAGGLUTININ; NONSTRUCTURAL PROTEIN 1; SIALIDASE; VIRULENCE FACTOR;

ADAPTATION; GENE; GENETIC IDENTIFICATION; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; PANDEMIC; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VIRULENCE; VIRUS GENE; VIRUS PB1 GENE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

DISEASE OUTBREAKS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; VIRULENCE;

ORTHOMYXOVIRIDAE;

EID: 70349547208     PISSN: 00664227     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.micro.091208.073359     Document Type: Review

References (125)

1. 2004. WHO Manual on Animal Influenza Diagnosis and Surveillance. Geneva: WHO
2. 2008. Online report: toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1). Emerg. Infect. Dis. 14:e1
3. 2009. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. Geneva: WHO
4. Alford RH, Kasel JA, Gerone PJ, Knight V. 1966. Human influenza resulting from aerosol inhalation. Proc. Soc. Exp. Biol. Med. 122:800-804
5. Andrewes CH, Glover RE. 1941. Spread of infection from the respiratory tract of the ferret. I. Transmission of influenza A virus. Br. J. Exp. Pathol. 22:91-97
6. Andrews CH, Laidlaw PP, Smith W. 1935. Influenza: observations on the recovery of virus from man and on the antibody content of human sera. Br. J. Exp. Pathol. 17:579-581
7. Basler CF, Reid AH, Dybing JK, Janczewski TA, Fanning TG, et al. 2001. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc. Natl. Acad. Sci. USA 98:2746-2751
8. Bean B, Moore BM, Sterner B, Peterson LR, Gerding DN, Balfour HH Jr. 1982. Survival of influenza viruses on environmental surfaces. J. Infect. Dis. 146:47-51 (Pubitemid 12045334)
9. Bergmann M, Garcia-Sastre A, Carnero E, Pehamberger H, Wolff K, et al. 2000. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J. Virol. 74:6203-6206 (Pubitemid 30412995)
10. Biswas SK, Nayak DP. 1996. Influenza virus polymerase basic protein 1 interacts with influenza virus polymerase basic protein 2 at multiple sites. J. Virol. 70:6716-6722 (Pubitemid 26307378)
11. Chandrasekaran A, Srinivasan A, Raman R, Viswanathan K, Raguram S, et al. 2008. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat. Biotechnol. 26:107-113
12. Chanturiya AN, Basanez G, Schubert U, Henklein P, Yewdell JW, Zimmerberg J. 2004. PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes. J. Virol. 78:6304-6312 (Pubitemid 38715929)
13. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, et al. 2001. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7:1306-1312 (Pubitemid 34007934)
14. Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, et al. 1998. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351:472-477
15. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P. 2007. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 3:1414-1421 (Pubitemid 350085606)
16. Conn CA, McClellan JL, Maassab HF, Smitka CW, Majde JA, Kluger MJ. 1995. Cytokines and the acute phase response to influenza virus in mice. Am. J. Physiol. 268:R78-84
17. Connor RJ, Kawaoka Y, Webster RG, Paulson JC. 1994. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 205:17-23 (Pubitemid 24360586)
18. de Jong JC, Claas EC, Osterhaus AD, Webster RG, Lim WL. 1997. A pandemic warning? Nature 389:554
19. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, et al. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12:1203-1207 (Pubitemid 44527358)
20. Dong B, Silverman RH. 1995. 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J. Biol. Chem. 270:4133-4137
21. Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, Garcia-Sastre A. 1999. Rescue of influenza A virus from recombinant DNA. J. Virol. 73:9679-9682 (Pubitemid 29487131)
22. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, et al. 2005. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 79:2814-2822 (Pubitemid 40270559)
23. Gambaryan AS, Tuzikov AB, Piskarev VE, Yamnikova SS, Lvov DK, et al. 1997. Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: Nonegg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6′-sialyl(N-acetyllactosamine). Virology 232:345-350
24. Garcia-Sastre A. 2001. Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 279:375-384 (Pubitemid 34161101)
25. Garcia-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, et al. 1998. The role of interferon in influenza virus tissue tropism. J. Virol. 72:8550-8558 (Pubitemid 28471792)
26. Geiss GK, Salvatore M, Tumpey TM, Carter VS, Wang X, et al. 2002. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc. Natl. Acad. Sci. USA 99:10736-10741 (Pubitemid 34907046)
27. Ghanem A, Mayer D, Chase G, Tegge W, Frank R, et al. 2007. Peptide-mediated interference with influenza A virus polymerase. J. Virol. 81:7801-7804 (Pubitemid 47047866)
28. Gibbs MJ, Gibbs AJ. 2006. Molecular virology: Was the 1918 pandemic caused by a bird flu? Nature 440:E8-10
29. Glaser L, Stevens J, Zamarin D, Wilson IA, Garcia-Sastre A, et al. 2005. A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J. Virol. 79:11533-11536 (Pubitemid 41170697)
30. Glezen WP. 1996. Emerging infections: pandemic influenza. Epidemiol. Rev. 18:64-76
31. Gonzalez S, Zurcher T, Ortin J. 1996. Identification of two separate domains in the influenza virus PB1 protein involved in the interaction with the PB2 and PA subunits: a model for the viral RNA polymerase structure. Nucleic Acids Res. 24:4456-4463 (Pubitemid 26388631)
32. Goto H, Kawaoka Y. 1998. A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc. Natl. Acad. Sci. USA 95:10224-10228 (Pubitemid 28415322)
33. Goto H, Wells K, Takada A, Kawaoka Y. 2001. Plasminogen-binding activity of neuraminidase determines the pathogenicity of influenza A virus. J. Virol. 75:9297-9301 (Pubitemid 32851933)
34. Hartley CA, Reading PC, Ward AC, Anders EM. 1997. Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice. Arch. Virol. 142:75-88
35. Hatada E, Saito S, Fukuda R. 1999. Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J. Virol. 73:2425-2433 (Pubitemid 29098149)
36. Hatta M, Hatta Y, Kim JH, Watanabe S, Shinya K, et al. 2007. Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog. 3:1374-1379 (Pubitemid 350085602)
37. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. 1998. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J. Clin. Investig. 101:643-649 (Pubitemid 28084248)
38. Ibricevic A, Pekosz A, Walter MJ, Newby C, Battaile JT, et al. 2006. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J. Virol. 80:7469-7480 (Pubitemid 44092569)
39. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ. 1993. Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am. J. Physiol. 264:G801-9 (Pubitemid 23124784)
40. Johnson NP, Mueller J. 2002. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull. Hist. Med. 76:105-115
41. Kandun IN, Wibisono H, Sedyaningsih ER, Yusharmen, Hadisoedarsuno W, et al. 2006. Three Indonesian clusters of H5N1 virus infection in 2005. N. Engl. J. Med. 355:2186-2194 (Pubitemid 44791160)
42. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, et al. 2006. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443:578-581 (Pubitemid 44527293)
43. Katz JM, Lu X, Tumpey TM, Smith CB, Shaw MW, Subbarao K. 2000. Molecular correlates of influenza A H5N1 virus pathogenesis in mice. J. Virol. 74:10807-10810 (Pubitemid 30815404)
44. Kaverin NV, Finskaya NN, Rudneva IA, Gitelman AK, Kharitonenkov IG, Smirnov YA. 1989. Studies on the genetic basis of human influenza A virus adaptation to mice: degrees of virulence of reassortants with defined genetic content. Arch. Virol. 105:29-37
45. Kawaoka Y, Krauss S, Webster RG. 1989. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J. Virol. 63:4603-4608 (Pubitemid 19257834)
46. Keleta L, Ibricevic A, Bovin NV, Brody SL, Brown EG. 2008. Experimental evolution of human influenza virus H3 hemagglutinin in the mouse lung identifies adaptive regions in HA1 and HA2. J. Virol. 82:11599-11608
47. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, et al. 2007. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445:319-323 (Pubitemid 46122819)
48. Kobasa D, Takada A, Shinya K, Hatta M, Halfmann P, et al. 2004. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431:703-707 (Pubitemid 39382618)
49. Lamb RA, Takeda M. 2001. Death by influenza virus protein. Nat. Med. 7:1286-1288
50. LeCount ER. 1919. The pathologic anatomy of influenzal bronchopneumonia. JAMA 72:650-652
51. Li S, Schulman J, Itamura S, Palese P. 1993. Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. J. Virol. 67:6667-6673 (Pubitemid 23309134)
52. Lidwell OM. 1974. Aerial dispersal of micro-organisms from the human respiratory tract. Soc. Appl. Bacteriol. Symp. Ser. 3:135-154
53. Lowen AC, Mubareka S, Steel J, Palese P. 2007. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog. 3:1470-1476 (Pubitemid 350085611)
54. Lowen AC, Mubareka S, Tumpey TM, Garcia-Sastre A, Palese P. 2006. The guinea pig as a transmission model for human influenza viruses. Proc. Natl. Acad. Sci. USA 103:9988-9992 (Pubitemid 43993610)
55. Lowen AC, Steel J, Mubareka S, Palese P. 2008. High temperature (30°C) blocks aerosol but not contact transmission of influenza virus. J. Virol. 82:5650-5652 (Pubitemid 351705272)
56. Lu Y, Wambach M, Katze MG, Krug RM. 1995. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214:222-228
57. Ludwig S, Pleschka S, Wolff T. 1999. A fatal relationship - influenza virus interactions with the host cell. Viral. Immunol. 12:175-196 (Pubitemid 29487628)
58. Maines TR, Chen LM, Matsuoka Y, Chen H, Rowe T, et al. 2006. Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc. Natl. Acad. Sci. USA 103:12121-12126 (Pubitemid 44215821)
59. Massin P, Van Der Werf S, Naffakh N. 2001. Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses. J. Virol. 75:5398-5404 (Pubitemid 32448565)
60. Matrosovich M, Zhou N, Kawaoka Y, Webster R. 1999. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J. Virol. 73:1146-1155 (Pubitemid 29036766)
61. Matrosovich MN, Gambaryan AS, Teneberg S, Piskarev VE, Yamnikova SS, et al. 1997. Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology 233:224-234 (Pubitemid 27348784)
62. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD. 2004. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. USA 101:4620-4624 (Pubitemid 38437460)
63. McAuley JL, Hornung F, Boyd KL, Smith AM, McKeon R, et al. 2007. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbes 2:240-249 (Pubitemid 47500821)
64. Min JY, Krug RM. 2006. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc. Natl. Acad. Sci. USA 103:7100-7105
65. Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, et al. 2000. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J. Virol. 74:6015-6020
66. Moss B, Keith JM, Gershowitz A, Ritchey MB, Palese P. 1978. Common sequence at the 5′ ends of the segmented RNA genomes of influenza A and B viruses. J. Virol. 25:312-318 (Pubitemid 8258154)
67. Munster VJ, de Wit E, van Riel D, Beyer WE, Rimmelzwaan GF, et al. 2007. The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses. J. Infect. Dis. 196:258-265
68. Naeve CW, Hinshaw VS, Webster RG. 1984. Mutations in the hemagglutinin receptor-binding site can change the biological properties of an influenza virus. J. Virol. 51:567-569
69. Naffakh N, Massin P, Escriou N, Crescenzo-Chaigne B, Van DerWerf S. 2000. Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A viruses. J. Gen. Virol. 81:1283-1291 (Pubitemid 30232714)
70. OIE. 1996. Highly pathogenic avian influenza (fowl plague). In Manual of Standards for Diagnostic Tests and Vaccines, ed. GA Cullen, S Linnance, pp. 155-160 Paris: OIE. 3rd ed.
71. Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, et al. 2007. IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol. 9:930-938 (Pubitemid 46394904)
72. Palese P, Shaw ML. 2006. Orthomyxoviridae: the viruses and their replication. In Field's Virology, ed. DM Knipe, pp. 1648-1689 Philadelphia: Lippincott Williams & Wilkins
73. Palese P, Tobita K, Ueda M, Compans RW. 1974. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61:397-410
74. Pappas C, Aguilar PV, Basler CF, Solorzano A, Zeng H, et al. 2008. Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc. Natl. Acad. Sci. USA 105:3064-3069 (Pubitemid 351723668)
75. Perez DR, Donis RO. 2001. Functional analysis of PA binding by influenza a virus PB1: effects on polymerase activity and viral infectivity. J. Virol. 75:8127-8136
76. Reid AH, Fanning TG, Hultin JV, Taubenberger JK. 1999. Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene. Proc. Natl. Acad. Sci. USA 96:1651-1656
77. Reid AH, Fanning TG, Janczewski TA, Lourens RM, Taubenberger JK. 2004. Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. J. Virol. 78:12462-12470 (Pubitemid 39458764)
78. Reid AH, Fanning TG, Janczewski TA, McCall S, Taubenberger JK. 2002. Characterization of the 1918 "Spanish" influenza virus matrix gene segment. J. Virol. 76:10717-10723
79. Reid AH, Fanning TG, Janczewski TA, Taubenberger JK. 2000. Characterization of the 1918 "Spanish" influenza virus neuraminidase gene. Proc. Natl. Acad. Sci. USA 97:6785-6790
80. Rogers GN, D'Souza BL. 1989. Receptor binding properties of human and animal H1 influenza virus isolates. Virology 173:317-322 (Pubitemid 19268276)
81. Salomon R, Franks J, Govorkova EA, Ilyushina NA, Yen HL, et al. 2006. The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J. Exp. Med. 203:689-697
82. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. 2006. Avian flu: influenza virus receptors in the human airway. Nature 440:435-436
83. Shinya K, Hamm S, Hatta M, Ito H, Ito T, Kawaoka Y. 2004. PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. Virology 320:258-266 (Pubitemid 38315152)
84. Shinya K, Watanabe S, Ito T, Kasai N, Kawaoka Y. 2007. Adaptation of an H7N7 equine influenza A virus in mice. J. Gen. Virol. 88:547-553 (Pubitemid 46210894)
85. Shope RE. 1936. The incidence of neutralizing antibodies for severe influenza virus in the sera of human beings of different ages. J. Exp. Med. 63:655-659
86. Simonet WS, Hughes TM, Nguyen HQ, Trebasky LD, Danilenko DM, Medlock ES. 1994. Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J. Clin. Investig. 94:1310-1319
87. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. 1998. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J. Infect. Dis. 178:53-60 (Pubitemid 28328076)
88. Skehel JJ, Wiley DC. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531-569
89. Smeenk CA, Wright KE, Burns BF, Thaker AJ, Brown EG, 1996. Mutations in the hemagglutinin and matrix genes of a virulent influenza virus variant, A/FM/1/47-MA, control different stages in pathogenesis. Virus Res. 44:79-95
90. Srinivasan A, Viswanathan K, Raman R, Chandrasekaran A, Raguram S, et al. 2008. Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses. Proc. Natl. Acad. Sci. USA 105:2800-2805 (Pubitemid 351723624)
91. Steel J, Lowen AC, Mubareka S, Palese P. 2009. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog. 5:e1000252
92. Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA. 2006. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312:404-410
93. Subbarao EK, London W, Murphy BR. 1993. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J. Virol. 67:1761-1764 (Pubitemid 23088345)
94. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, et al. 1998. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279:393-396 (Pubitemid 28063376)
95. Swayne DE, Pantin-Jackwood M. 2006. Pathogenicity of avian influenza viruses in poultry. Dev. Biol. 124:61-67 (Pubitemid 43258900)
96. Swayne DE, Suarez DL. 2000. Highly pathogenic avian influenza. Rev. Sci. Tech. 19:463-482
97. Tan SL, Katze MG. 1998. Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J. Interferon Cytokine Res. 18:757-766
98. Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE, Fanning TG. 1997. Initial genetic characterization of the 1918 "Spanish" influenza virus. Science 275:1793-1796
99. Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG. 2005. Characterization of the 1918 influenza virus polymerase genes. Nature 437:889-893 (Pubitemid 41486764)
100. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, et al. 2004. Influenza-associated hospitalizations in the United States. JAMA 292:1333-1340
101. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, et al. 2003. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:179-186 (Pubitemid 36068705)
102. Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, et al. 2004. Avian influenza A (H5N1) in 10 patients in Vietnam. N. Engl. J. Med. 350:1179-1188 (Pubitemid 38339362)
103. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solorzano A, et al. 2005. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310:77-80 (Pubitemid 41434537)
104. Tumpey TM, Garcia-Sastre A, Mikulasova A, Taubenberger JK, Swayne DE, et al. 2002. Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc. Natl. Acad. Sci. USA 99:13849-13854 (Pubitemid 35215469)
105. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Basler CF. 2004. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc. Natl. Acad. Sci. USA 101:3166-3171 (Pubitemid 38327752)
106. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, et al. 2005. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J. Virol. 79:14933-14944 (Pubitemid 41636290)
107. Tumpey TM, Lu X, Morken T, Zaki SR, Katz JM. 2000. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J. Virol. 74:6105-6116 (Pubitemid 30412982)
108. Tumpey TM, Maines TR, Van Hoeven N, Glaser L, Solorzano A, et al. 2007. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315:655-659 (Pubitemid 46214711)
109. Van Hoeven N, Pappas C, Belser JA, Maines TR, Zeng H, et al. 2009. Human hemagglutinin and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc. Natl. Acad. Sci. USA 106:3366-3371
110. van Riel D, Munster VJ, deWit E, Rimmelzwaan GF, Fouchier RA, et al. 2006. H5N1 virus attachment to lower respiratory tract. Science 312:399
111. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, et al. 2007. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am. J. Pathol. 171:1215-1223
112. Wagner R, Matrosovich M, Klenk HD. 2002. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev. Med. Virol. 12:159-166 (Pubitemid 34516947)
113. Wagner R, Wolff T, Herwig A, Pleschka S, Klenk HD. 2000. Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics. J. Virol. 74:6316-6323 (Pubitemid 30429796)
114. Wang X, Li M, Zheng H, Muster T, Palese P, et al. 2000. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J. Virol. 74:11566-11573 (Pubitemid 32222305)
115. Weber F, Kochs G, Haller O. 2004. Inverse interference: how viruses fight the interferon system. Viral Immunol. 17:498-515 (Pubitemid 40054230)
116. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. 1992. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56:152-179
117. Webster RG, Yakhno M, Hinshaw VS, Bean WJ, Murti KG. 1978. Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology 84:268-278 (Pubitemid 8286072)
118. Yao L, Korteweg C, Hsueh W, Gu J. 2008. Avian influenza receptor expression in H5N1-infected and noninfected human tissues. FASEB J. 22:733-740 (Pubitemid 351348126)
119. Yen HL, Lipatov AS, Ilyushina NA, Govorkova EA, Franks J, et al. 2007. Inefficient transmission of H5N1 influenza viruses in a ferret contact model. J. Virol. 81:6890-6898 (Pubitemid 46986625)
120. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737 (Pubitemid 39023305)
121. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, et al. 1998. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351:467-471 (Pubitemid 28070092)
122. Zamarin D, Garcia-Sastre A, Xiao X, Wang R, Palese P. 2005. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog. 1:e4
123. Zamarin D, Ortigoza MB, Palese P. 2006. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J. Virol. 80:7976-7983 (Pubitemid 44182298)
124. Zell R, Krumbholz A, Eitner A, Krieg R, Halbhuber KJ, Wutzler P. 2007. Prevalence of PB1-F2 of influenza A viruses. J. Gen. Virol. 88:536-546
125. Zhou A, Paranjape J, Brown TL, Nie H, Naik S, et al. 1997. Interferon action and apoptosis are defective in mice devoid of 2′,5′- oligoadenylate-dependent RNase L. EMBO J. 16:6355-6363 (Pubitemid 27483262)